僑銀股份(002973.SZ):預中標約8.95億元恩平中心城區和工業園區環衞一體化和市場化項目
格隆匯12月16日丨僑銀股份(002973.SZ)公佈,近日,公司預中標恩平中心城區和工業園區環衞一體化和市場化項目,中標(成交)金額約8.95億元。
運營期限:9年,採用3+3+3模式,從合同簽訂之日起算,中標後簽訂第一個三年合同,第一個三年內每年度考核得分(按每年度所有月份的平均考核計算)達到良好(90分)則續簽第2個三年合同,第2個三年內每年度考核得分達到良好則續簽第3個三年合同,每3年按5%的固定幅度遞增運營費用;
服務範圍:本項目服務範圍為恩平市中心城區、工業園區的環衞保潔、垃圾收運、綠化養護及其他10個鄉鎮的垃圾收運。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.